Skip to main content

Roche’s Virtual Early Drug Development pRED Event 2019

Roche has hosted a live video webcast and conference call on Monday, 11 November 2019.

agenda
Agenda:
WelcomeKarl Mahler, Head of Investor Relations
Overview and introduction to Roche pRED William Pao, Head of Roche Pharma Research and Early Development
OncologyChristian Rommel, Global Head of pRED Oncology
NeuroscienceAzad Bonni, Global Head of pRED Neuroscience and Rare Diseases
OphthalmologySascha Fauser, Global Head of pRED Ophthalmology
Q&A

Please register to access the replay* *Privacy notice

Live webinar replay

Confirm you are a human *
InvestorsPast IR Events
View more Events

Related links

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Roche’s Annual Report 2018

    Investors

    How digital innovation increases patient benefit in the future.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions